Centessa Depreciation And Amortization from 2010 to 2025
| CNTA Stock | USD 15.75 0.54 3.31% |
Depreciation And Amortization | First Reported 2010-12-31 | Previous Quarter 935.1 K | Current Value 981.9 K | Quarterly Volatility 328.8 K |
Check Centessa Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Centessa Pharmaceuticals' main balance sheet or income statement drivers, such as Interest Income of 12.6 M, Depreciation And Amortization of 981.9 K or Interest Expense of 12 M, as well as many indicators such as Price To Sales Ratio of 89.37, Dividend Yield of 0.0 or PTB Ratio of 3.06. Centessa financial statements analysis is a perfect complement when working with Centessa Pharmaceuticals Valuation or Volatility modules.
Centessa | Depreciation And Amortization |
Latest Centessa Pharmaceuticals' Depreciation And Amortization Growth Pattern
Below is the plot of the Depreciation And Amortization of Centessa Pharmaceuticals PLC over the last few years. It is the systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives. Centessa Pharmaceuticals' Depreciation And Amortization historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Centessa Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| Depreciation And Amortization | 10 Years Trend |
|
Depreciation And Amortization |
| Timeline |
Centessa Depreciation And Amortization Regression Statistics
| Arithmetic Mean | 253,814 | |
| Geometric Mean | 132,286 | |
| Coefficient Of Variation | 129.55 | |
| Mean Deviation | 246,084 | |
| Median | 116,000 | |
| Standard Deviation | 328,819 | |
| Sample Variance | 108.1B | |
| Range | 975.9K | |
| R-Value | 0.65 | |
| Mean Square Error | 67.6B | |
| R-Squared | 0.42 | |
| Significance | 0.01 | |
| Slope | 44,581 | |
| Total Sum of Squares | 1.6T |
Centessa Depreciation And Amortization History
About Centessa Pharmaceuticals Financial Statements
Centessa Pharmaceuticals stakeholders use historical fundamental indicators, such as Centessa Pharmaceuticals' Depreciation And Amortization, to determine how well the company is positioned to perform in the future. Although Centessa Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. For example, changes in Centessa Pharmaceuticals' assets and liabilities are reflected in the revenues and expenses on Centessa Pharmaceuticals' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Centessa Pharmaceuticals PLC. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Depreciation And Amortization | 935.1 K | 981.9 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Check out the analysis of Centessa Pharmaceuticals Correlation against competitors. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Centessa Pharmaceuticals. If investors know Centessa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Centessa Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Centessa Pharmaceuticals is measured differently than its book value, which is the value of Centessa that is recorded on the company's balance sheet. Investors also form their own opinion of Centessa Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Centessa Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Centessa Pharmaceuticals' market value can be influenced by many factors that don't directly affect Centessa Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Centessa Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Centessa Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Centessa Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.